-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QvT8TrTc3goxeBfwTyv8Z1GS4NAkivuoCcw2gr3cikfx1dGoVzeTRwF7c9ySvyBB GAznWvPLAREwlmu8LiB5/Q== 0001361106-08-000480.txt : 20090522 0001361106-08-000480.hdr.sgml : 20090522 20081125131421 ACCESSION NUMBER: 0001361106-08-000480 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20081125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POWER 3 MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001063530 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 650565144 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3400 RESEARCH FOREST DR STREET 2: SUITE B2-3 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 281-466-1600 MAIL ADDRESS: STREET 1: 3400 RESEARCH FOREST DR STREET 2: SUITE B2-3 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: SURGICAL SAFETY PRODUCTS INC DATE OF NAME CHANGE: 19980924 CORRESP 1 filename1.htm power3_corresp-112508.htm
Power3 Medical Products, Inc.
3400 Research Forest Drive, Suite B2-3
The Woodlands, Texas  77381

 
November 25, 2008


Via EDGAR

Mr. Jeffery Riedler, Assistant Director
United States Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, DC 20549

Re:   Power3 Medical Products, Inc.
 Preliminary Proxy Statement on Schedule 14A
 Filed November 13, 2008
 File No. 000-24921

Dear Mr. Riedler:

Power3 Medical Products, Inc., a New York corporation (the “Company”), hereby submits the statement set forth below relating to your Comment Letter to the Company dated November 21, 2008 (the “Comment Letter”) pertaining to the Company’s Preliminary Proxy Statement on Schedule 14A referenced above.
 
The Company hereby acknowledges each of the following:
 
·       
The Company is responsible for the adequacy and accuracy of the disclosure in the filing;
 
·       
Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
 
·       
The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
 
 
United States Securities and Exchange Commission
November 25, 2008
Page 2
 
Should you have any additional questions please contact me at (281) 466-1600 or our outside counsel J. William Wilson, Esq. at Phillips & Reiter, PLLC at (512) 646-1104.
 
 
  Very truly yours, 
   
  /s/ IRA L. GOLDKNOPF 
  Ira L. Goldknopf 
  President and Chief Science Officer 
 
 
cc:           Sonia Barros, Division of Corporation Finance
J. William Wilson, Phillips & Reiter, PLLC

 -----END PRIVACY-ENHANCED MESSAGE-----